CAPECITABINE\OXALIPLATIN: 90 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
90
Total FAERS Reports
14 (15.6%)
Deaths Reported
28
Hospitalizations
90
As Primary/Secondary Suspect
12
Life-Threatening
First Report: 201007 · Latest Report: 20250313
What Are the Most Common CAPECITABINE\OXALIPLATIN Side Effects?
#1 Most Reported
Diarrhoea
11 reports (12.2%)
#2 Most Reported
Malignant neoplasm progression
8 reports (8.9%)
#3 Most Reported
Death
8 reports (8.9%)
All CAPECITABINE\OXALIPLATIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 11 | 12.2% | 1 | 6 |
| Death | 8 | 8.9% | 8 | 1 |
| Malignant neoplasm progression | 8 | 8.9% | 2 | 3 |
| Neuropathy peripheral | 6 | 6.7% | 0 | 1 |
| Therapy partial responder | 6 | 6.7% | 3 | 0 |
| Colorectal cancer metastatic | 5 | 5.6% | 3 | 0 |
| Enterocolitis | 5 | 5.6% | 0 | 5 |
| Nausea | 5 | 5.6% | 1 | 5 |
| Osteonecrosis of jaw | 5 | 5.6% | 0 | 0 |
| Product use in unapproved indication | 5 | 5.6% | 2 | 0 |
| Vomiting | 5 | 5.6% | 1 | 4 |
Who Reports CAPECITABINE\OXALIPLATIN Side Effects? Age & Gender Data
Gender: 35.1% female, 64.9% male. Average age: 62.5 years. Most reports from: US. View detailed demographics →
Is CAPECITABINE\OXALIPLATIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 1 | 1 |
| 2012 | 5 | 0 | 0 |
| 2014 | 1 | 1 | 0 |
| 2016 | 2 | 0 | 1 |
| 2018 | 2 | 0 | 1 |
| 2019 | 2 | 0 | 2 |
| 2020 | 1 | 1 | 1 |
| 2021 | 3 | 1 | 1 |
| 2022 | 5 | 0 | 2 |
| 2023 | 7 | 0 | 0 |
| 2024 | 3 | 0 | 2 |
| 2025 | 1 | 0 | 0 |
What Is CAPECITABINE\OXALIPLATIN Used For?
| Indication | Reports |
|---|---|
| Gastric cancer | 10 |
| Colorectal cancer | 9 |
| Colorectal cancer metastatic | 9 |
| Product used for unknown indication | 9 |
| Adenocarcinoma gastric | 6 |
| Plasma cell myeloma | 5 |
Official FDA Label for CAPECITABINE\OXALIPLATIN
Official prescribing information from the FDA-approved drug label.